MENU

EDIT Editas Medicine Forecast, Technical & Fundamental Analysis

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases... Show more

Industry: #Biotechnology
EDIT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
EDIT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EDIT is expected to report earnings to rise 30.87% to -19 cents per share on November 09

Editas Medicine EDIT Stock Earnings Reports
Q3'26
Est.
$-0.20
Q2'26
Beat
by $0.12
Q1'26
Beat
by $0.01
Q4'25
Beat
by $0.17
Q3'25
Beat
by $0.02
The last earnings report on August 05 showed earnings per share of -15 cents, beating the estimate of -27 cents. With 767.33K shares outstanding, the current market capitalization sits at 473.03M.
A.I. Advisor
published General Information

General Information

a company which translates genome editing technology into a novel class of human therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
11 Hurley Street
Phone
+1 617 401-9000
Employees
87
Web
https://www.editasmedicine.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JORIX21.59N/A
N/A
Janus Henderson Global Select S
GSXAX46.51N/A
N/A
abrdn US Small Cap Equity A
JUSMX21.83N/A
N/A
JPMorgan US Small Company R6
ETCEX16.47N/A
N/A
Eventide Exponential Technologies C
TIBRX38.47-0.16
-0.41%
Thornburg Investment Income Builder R3

EDIT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with BEAM. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
+0.33%
BEAM - EDIT
65%
Loosely correlated
+0.93%
CRBU - EDIT
65%
Loosely correlated
+3.23%
PRME - EDIT
64%
Loosely correlated
+2.80%
NTLA - EDIT
60%
Loosely correlated
+0.59%
CRSP - EDIT
59%
Loosely correlated
+0.18%
More
Editas Medicine (EDIT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com